The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer.
(2003) In Advances in Experimental Medicine and Biology 525. p.201-204- Abstract
- The metabolites of arachidonic acid are well connected to pathological situations such as inflammation, cancer and asthmA. Sheng et al. [7] found that COX-2 is upregulated in colon cancer tissue and tumor cell lines indicating that COX-2 is involved in colon cancer. This is supported by studies showing that patients treated with nonsteroidal anti-inflammatory drugs, inhibitors of COX-2, exhibit a lower frequency of colon cancer [8]. When the non-transformed intestinal epithelial cell line, Int 407 was stimulated with LTD4 or LTB4 we observed an accumulation of COX-2 in membrane fractions as well as an increased production of prostaglandin E2 [5]. Treatment of these cells with the COX-2 inhibitor NS-398 caused apoptosis and this effect... (More)
- The metabolites of arachidonic acid are well connected to pathological situations such as inflammation, cancer and asthmA. Sheng et al. [7] found that COX-2 is upregulated in colon cancer tissue and tumor cell lines indicating that COX-2 is involved in colon cancer. This is supported by studies showing that patients treated with nonsteroidal anti-inflammatory drugs, inhibitors of COX-2, exhibit a lower frequency of colon cancer [8]. When the non-transformed intestinal epithelial cell line, Int 407 was stimulated with LTD4 or LTB4 we observed an accumulation of COX-2 in membrane fractions as well as an increased production of prostaglandin E2 [5]. Treatment of these cells with the COX-2 inhibitor NS-398 caused apoptosis and this effect could be prevented by LTD4 [5] or LTB4 [4]. Similar results were obtained when cell viability with LTD4 or LTB4 in the presence or absence of NS-398 was assayed [4,5]. The results demonstrate that these leukotrienes can suppress the NS-398 induced apoptosis in intestinal cells. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/113976
- author
- Kamp-Nielsen, Christian LU ; Öhd, John LU ; Wikström, Katarina LU ; Massoumi, Ramin LU ; Paruchuri, Sailaja LU ; Juhas, Maria LU and Sjölander, Anita LU
- organization
- publishing date
- 2003
- type
- Chapter in Book/Report/Conference proceeding
- publication status
- published
- subject
- host publication
- Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research
- series title
- Advances in Experimental Medicine and Biology
- volume
- 525
- pages
- 201 - 204
- publisher
- Springer
- external identifiers
-
- wos:000183072500043
- pmid:12751768
- scopus:0037530152
- ISSN
- 0065-2598
- ISBN
- 978-0-306-47763-8
- DOI
- 10.1007/978-1-4419-9194-2_43
- language
- English
- LU publication?
- yes
- id
- 7bd8c4c1-2b3e-4e99-82ae-e4eccde3302c (old id 113976)
- date added to LUP
- 2016-04-01 15:45:17
- date last changed
- 2022-01-28 06:54:55
@inbook{7bd8c4c1-2b3e-4e99-82ae-e4eccde3302c, abstract = {{The metabolites of arachidonic acid are well connected to pathological situations such as inflammation, cancer and asthmA. Sheng et al. [7] found that COX-2 is upregulated in colon cancer tissue and tumor cell lines indicating that COX-2 is involved in colon cancer. This is supported by studies showing that patients treated with nonsteroidal anti-inflammatory drugs, inhibitors of COX-2, exhibit a lower frequency of colon cancer [8]. When the non-transformed intestinal epithelial cell line, Int 407 was stimulated with LTD4 or LTB4 we observed an accumulation of COX-2 in membrane fractions as well as an increased production of prostaglandin E2 [5]. Treatment of these cells with the COX-2 inhibitor NS-398 caused apoptosis and this effect could be prevented by LTD4 [5] or LTB4 [4]. Similar results were obtained when cell viability with LTD4 or LTB4 in the presence or absence of NS-398 was assayed [4,5]. The results demonstrate that these leukotrienes can suppress the NS-398 induced apoptosis in intestinal cells.}}, author = {{Kamp-Nielsen, Christian and Öhd, John and Wikström, Katarina and Massoumi, Ramin and Paruchuri, Sailaja and Juhas, Maria and Sjölander, Anita}}, booktitle = {{Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research}}, isbn = {{978-0-306-47763-8}}, issn = {{0065-2598}}, language = {{eng}}, pages = {{201--204}}, publisher = {{Springer}}, series = {{Advances in Experimental Medicine and Biology}}, title = {{The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer.}}, url = {{http://dx.doi.org/10.1007/978-1-4419-9194-2_43}}, doi = {{10.1007/978-1-4419-9194-2_43}}, volume = {{525}}, year = {{2003}}, }